Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis

Objective: Interleukin 8 protein promotes inflammatory responses, even in airways. The presence of interleukin 8 gene variants causes altered inflammatory responses and possibly varied responses to inhaled bronchodilators. Thus, this study analyzed the interleukin 8 variants (rs4073, rs2227306, and...

Full description

Bibliographic Details
Main Authors: Larissa Lazzarini Furlan, José Dirceu Ribeiro, Carmen Sílvia Bertuzzo, João Batista Salomão Junior, Dorotéia Rossi Silva Souza, Fernando Augusto Lima Marson
Format: Article
Language:Portuguese
Published: Brazilian Society of Pediatrics 2017-11-01
Series:Jornal de Pediatria (Versão em Português)
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2255553617300794
_version_ 1811248728708743168
author Larissa Lazzarini Furlan
José Dirceu Ribeiro
Carmen Sílvia Bertuzzo
João Batista Salomão Junior
Dorotéia Rossi Silva Souza
Fernando Augusto Lima Marson
author_facet Larissa Lazzarini Furlan
José Dirceu Ribeiro
Carmen Sílvia Bertuzzo
João Batista Salomão Junior
Dorotéia Rossi Silva Souza
Fernando Augusto Lima Marson
author_sort Larissa Lazzarini Furlan
collection DOAJ
description Objective: Interleukin 8 protein promotes inflammatory responses, even in airways. The presence of interleukin 8 gene variants causes altered inflammatory responses and possibly varied responses to inhaled bronchodilators. Thus, this study analyzed the interleukin 8 variants (rs4073, rs2227306, and rs2227307) and their association with the response to inhaled bronchodilators in cystic fibrosis patients. Methods: Analysis of interleukin 8 gene variants was performed by restriction fragment length polymorphism of polymerase chain reaction. The association between spirometry markers and the response to inhaled bronchodilators was evaluated by Mann‐Whitney and Kruskal‐Wallis tests. The analysis included all cystic fibrosis patients, and subsequently patients with two mutations in the cystic fibrosis transmembrane conductance regulator gene belonging to classes I to III. Results: This study included 186 cystic fibrosis patients. There was no association of the rs2227307 variant with the response to inhaled bronchodilators. The rs2227306 variant was associated with FEF50% in the dominant group and in the group with two identified mutations in the cystic fibrosis transmembrane conductance regulator gene. The rs4073 variant was associated with spirometry markers in four genetic models: co‐dominant (FEF25‐75% and FEF75%), dominant (FEV1, FEF50%, FEF75%, and FEF25‐75%), recessive (FEF75% and FEF25‐75%), and over‐dominant (FEV1/FVC). Conclusions: This study highlighted the importance of the rs4073 variant of the interleukin 8 gene, regarding response to inhaled bronchodilators, and of the assessment of mutations in the cystic fibrosis transmembrane conductance regulator gene.
first_indexed 2024-04-12T15:33:14Z
format Article
id doaj.art-2ce0928fa20f4affa7e799ab515469a3
institution Directory Open Access Journal
issn 2255-5536
language Portuguese
last_indexed 2024-04-12T15:33:14Z
publishDate 2017-11-01
publisher Brazilian Society of Pediatrics
record_format Article
series Jornal de Pediatria (Versão em Português)
spelling doaj.art-2ce0928fa20f4affa7e799ab515469a32022-12-22T03:27:01ZporBrazilian Society of PediatricsJornal de Pediatria (Versão em Português)2255-55362017-11-0193663964810.1016/j.jpedp.2017.07.002Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosisLarissa Lazzarini Furlan0José Dirceu Ribeiro1Carmen Sílvia Bertuzzo2João Batista Salomão Junior3Dorotéia Rossi Silva Souza4Fernando Augusto Lima Marson5Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, BrasilUniversidade Estadual de Campinas (Unicamp), Faculdade de Ciências Médicas, Departamento de Pediatria, Campinas, SP, BrasilUniversidade Estadual de Campinas (Unicamp), Faculdade de Ciências Médicas, Departamento de Genética Médica, Campinas, SP, BrasilFaculdade de Medicina de São José do Rio Preto, Hospital Universitário, Departamento de Pediatria, São José do Rio Preto, SP, BrasilFaculdade de Medicina de São José do Rio Preto, Centro de Pesquisa de Bioquímica e Biologia Molecular, Departamento de Biologia Molecular, São José do Rio Preto, SP, BrasilUniversidade Estadual de Campinas (Unicamp), Faculdade de Ciências Médicas, Departamento de Pediatria, Campinas, SP, BrasilObjective: Interleukin 8 protein promotes inflammatory responses, even in airways. The presence of interleukin 8 gene variants causes altered inflammatory responses and possibly varied responses to inhaled bronchodilators. Thus, this study analyzed the interleukin 8 variants (rs4073, rs2227306, and rs2227307) and their association with the response to inhaled bronchodilators in cystic fibrosis patients. Methods: Analysis of interleukin 8 gene variants was performed by restriction fragment length polymorphism of polymerase chain reaction. The association between spirometry markers and the response to inhaled bronchodilators was evaluated by Mann‐Whitney and Kruskal‐Wallis tests. The analysis included all cystic fibrosis patients, and subsequently patients with two mutations in the cystic fibrosis transmembrane conductance regulator gene belonging to classes I to III. Results: This study included 186 cystic fibrosis patients. There was no association of the rs2227307 variant with the response to inhaled bronchodilators. The rs2227306 variant was associated with FEF50% in the dominant group and in the group with two identified mutations in the cystic fibrosis transmembrane conductance regulator gene. The rs4073 variant was associated with spirometry markers in four genetic models: co‐dominant (FEF25‐75% and FEF75%), dominant (FEV1, FEF50%, FEF75%, and FEF25‐75%), recessive (FEF75% and FEF25‐75%), and over‐dominant (FEV1/FVC). Conclusions: This study highlighted the importance of the rs4073 variant of the interleukin 8 gene, regarding response to inhaled bronchodilators, and of the assessment of mutations in the cystic fibrosis transmembrane conductance regulator gene.http://www.sciencedirect.com/science/article/pii/S2255553617300794CFTRDisease severityInterleukin 8Lung function
spellingShingle Larissa Lazzarini Furlan
José Dirceu Ribeiro
Carmen Sílvia Bertuzzo
João Batista Salomão Junior
Dorotéia Rossi Silva Souza
Fernando Augusto Lima Marson
Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
Jornal de Pediatria (Versão em Português)
CFTR
Disease severity
Interleukin 8
Lung function
title Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
title_full Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
title_fullStr Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
title_full_unstemmed Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
title_short Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
title_sort variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
topic CFTR
Disease severity
Interleukin 8
Lung function
url http://www.sciencedirect.com/science/article/pii/S2255553617300794
work_keys_str_mv AT larissalazzarinifurlan variantsintheinterleukin8geneandtheresponsetoinhaledbronchodilatorsincysticfibrosis
AT josedirceuribeiro variantsintheinterleukin8geneandtheresponsetoinhaledbronchodilatorsincysticfibrosis
AT carmensilviabertuzzo variantsintheinterleukin8geneandtheresponsetoinhaledbronchodilatorsincysticfibrosis
AT joaobatistasalomaojunior variantsintheinterleukin8geneandtheresponsetoinhaledbronchodilatorsincysticfibrosis
AT doroteiarossisilvasouza variantsintheinterleukin8geneandtheresponsetoinhaledbronchodilatorsincysticfibrosis
AT fernandoaugustolimamarson variantsintheinterleukin8geneandtheresponsetoinhaledbronchodilatorsincysticfibrosis